269 related articles for article (PubMed ID: 36228518)
1. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment.
He Z; Zhou H; Zhang Y; Du X; Liu S; Ji J; Yang X; Zhai G
Biomaterials; 2022 Nov; 290():121832. PubMed ID: 36228518
[TBL] [Abstract][Full Text] [Related]
2. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer
Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
[No Abstract] [Full Text] [Related]
3. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy.
Xu T; Ma Y; Yuan Q; Hu H; Hu X; Qian Z; Rolle JK; Gu Y; Li S
ACS Nano; 2020 Mar; 14(3):3414-3425. PubMed ID: 32155051
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
6. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles.
Xu Y; Yang L; Wang C; Sun W; Zheng Y; Ou B; Wu L; Shi L; Lin X; Chen W
J Control Release; 2024 Feb; 366():798-811. PubMed ID: 38184236
[TBL] [Abstract][Full Text] [Related]
9. Oxygen Self-Supplied Perfluorocarbon-Modified Micelles for Enhanced Cancer Photodynamic Therapy and Ferroptosis.
Ren H; Hao M; Liu G; Li J; Jiang Z; Meng W; Zhang Y
ACS Appl Bio Mater; 2024 May; 7(5):3306-3315. PubMed ID: 38634490
[TBL] [Abstract][Full Text] [Related]
10. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Ca
Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
[TBL] [Abstract][Full Text] [Related]
12. Periodic mesoporous organosilica coupled with chlorin e6 and catalase for enhanced photodynamic therapy to treat triple-negative breast cancer.
Tian W; Wang S; Tian Y; Su X; Sun H; Tang Y; Lu G; Liu S; Shi H
J Colloid Interface Sci; 2022 Mar; 610():634-642. PubMed ID: 34838318
[TBL] [Abstract][Full Text] [Related]
13. Catalytic nanographene oxide with hemin for enhanced photodynamic therapy.
Sahu A; Min K; Jeon J; Yang HS; Tae G
J Control Release; 2020 Oct; 326():442-454. PubMed ID: 32726649
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
15. Self-Assembling Porphyrins as a Single Therapeutic Agent for Synergistic Cancer Therapy: A One Stone Three Birds Strategy.
Chen J; Chen F; Zhang L; Yang Z; Deng T; Zhao Y; Zheng T; Gan X; Zhong H; Geng Y; Fu X; Wang Y; Yu C
ACS Appl Mater Interfaces; 2021 Jun; 13(24):27856-27867. PubMed ID: 34110146
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
[TBL] [Abstract][Full Text] [Related]
20. Ce6-modified Fe ions-doped carbon dots as multifunctional nanoplatform for ferroptosis and photodynamic synergistic therapy of melanoma.
Li H; Dou Y; Yang H; Xing H; Zhu C; Wang T; Xuan Z; Yang M
J Nanobiotechnology; 2024 Mar; 22(1):100. PubMed ID: 38462597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
